GPP
MTEM

Great Point Partners’s Molecular Templates, Inc. MTEM Stock Holding History

Great Point Partners’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,278
Closed -$858K – 28
2015
Q3 		$858K Buy
+1,278
New +$909K 0.34% 32

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Great Point Partners's MTEM Position: Q3 2020 in Review

Great Point Partners sold out of Molecular Templates, Inc. (MTEM) in Q3 2020, closing a stake of 89,693 shares — an estimated $18.6M sold.

Great Point Partners first reported a position in MTEM in Q4 2019 and held it in 3 quarters. The position peaked at $18.6M in Q2 2020. 103 funds tracked by Wall St. Rank hold MTEM as of Q3 2020.

  • Great Point Partners reported no remaining Molecular Templates, Inc. position as of Q3 2020 after selling out during the quarter.
  • Great Point Partners sold 89,693 Molecular Templates, Inc. shares in Q3 2020, an estimated $18.6M.
  • Great Point Partners first reported a position in Molecular Templates, Inc. in Q4 2019 and held it in 3 quarters.
  • Great Point Partners's Molecular Templates, Inc. position peaked at $18.6M in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2020.

Based on Great Point Partners's 13F filing for Q3 2020, filed 16 Nov 2020.